Nemaura Medical Statistics
Total Valuation
Nemaura Medical has a market cap or net worth of 4,035. The enterprise value is 19.51 million.
| Market Cap | 4,035 |
| Enterprise Value | 19.51M |
Important Dates
The last earnings date was Tuesday, February 11, 2025.
| Earnings Date | Feb 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nemaura Medical has 40.35 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 40.35M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 53.29% |
| Owned by Institutions (%) | 2.09% |
| Float | 14.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.83 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.00 |
Financial Position
The company has a current ratio of 0.19
| Current Ratio | 0.19 |
| Quick Ratio | 0.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.02 |
| Interest Coverage | -2.08 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -81.19% |
| Return on Invested Capital (ROIC) | -122.39% |
| Return on Capital Employed (ROCE) | 66.06% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -295,859 |
| Employee Count | 36 |
| Asset Turnover | n/a |
| Inventory Turnover | 0.49 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.87% in the last 52 weeks. The beta is 0.26, so Nemaura Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -99.87% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 50.79 |
| Average Volume (20 Days) | 463 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.04 |
Income Statement
| Revenue | n/a |
| Gross Profit | -1.48M |
| Operating Income | -11.78M |
| Pretax Income | -10.65M |
| Net Income | -10.65M |
| EBITDA | -11.29M |
| EBIT | -11.78M |
| Earnings Per Share (EPS) | -0.38 |
Balance Sheet
The company has 137,416 in cash and 19.64 million in debt, giving a net cash position of -19.51 million or -0.48 per share.
| Cash & Cash Equivalents | 137,416 |
| Total Debt | 19.64M |
| Net Cash | -19.51M |
| Net Cash Per Share | -0.48 |
| Equity (Book Value) | -17.83M |
| Book Value Per Share | -0.62 |
| Working Capital | -18.62M |
Cash Flow
In the last 12 months, operating cash flow was -9.57 million and capital expenditures -177,219, giving a free cash flow of -9.74 million.
| Operating Cash Flow | -9.57M |
| Capital Expenditures | -177,219 |
| Free Cash Flow | -9.74M |
| FCF Per Share | -0.24 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Nemaura Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.51% |
| Shareholder Yield | -18.51% |
| Earnings Yield | -263,963.64% |
| FCF Yield | -241,449.69% |
Stock Splits
The last stock split was on December 5, 2019. It was a reverse split with a ratio of 0.1.
| Last Split Date | Dec 5, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Nemaura Medical has an Altman Z-Score of -26.97. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -26.97 |
| Piotroski F-Score | n/a |